BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Mubritinib

0+ PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Mubritinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

cediranib
2 shared targets
gefitinib
2 shared targets
erlotinib
2 shared targets
neratinib
2 shared targets
canertinib
2 shared targets
vandetanib
2 shared targets
Dasatinib
2 shared targets
alvocidib
2 shared targets
foretinib
2 shared targets
bosutinib
2 shared targets
Loading evidence profile...

This evidence profile for Mubritinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.